DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000HC5HQ04

Real-time BOERSE MUENCHEN 12:47:07 23/05/2024 BST
0.099 EUR -29.29% Intraday chart for DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month-58.82%
1 month-62.16%
Date Price Change
23/05/24 0.099 -29.29%
22/05/24 0.14 -22.22%
21/05/24 0.18 -28.00%
20/05/24 0.25 0.00%
17/05/24 0.25 -21.88%

Real-time BOERSE MUENCHEN

Last update May 23, 2024 at 12:47 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HC5HQ0
ISINDE000HC5HQ04
Date issued 29/03/2023
Strike 45
Maturity 19/06/2024 (27 Days)
Parity 1 : 1
Emission price 1.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.02
Lowest since issue 0.074
Spread 0.028
Spread %28.57%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.75 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.82%
Consensus